英文别名 |
2-Heptenoic acid,7-[(1R,2R,3R)-3-hydroxy-2-[(1E,3S,5S)-3-hydroxy-5-methyl-1-nonen-1-yl]-5-oxocyclopentyl]-,(2E)-;(E)-7-[(1R,2R,3R)-3-hydroxy-2-[(E,3S,5S)-3-hydroxy-5-methylnon-1-enyl]-5-oxocyclopentyl]hept-2-enoic acid;11ALPHA,15S-DIHYDROXY-17S,20-DIMETHYL-9-OXO-PROSTA-2E,13E-DIEN-1-OIC ACID;2-Heptenoic acid,7-[(1R,2R,3R)-3-hydroxy-2-[(1E,3S,5S)-3-hydroxy-5-methyl-1-nonen-1-yl]-5-oxoc...;Limaprost;17S,20-Dimethyl-trans-2,3-didehydro-PGE1;17S,20-Dimethyl-trans-delta2-PGE1;17α,20-dimethyl-δ2-PGE1;ONO 1206;OP 1206;(2E,11Α,13E,15S,17S)-11,15-DIHYDROXY-17,20-DIMETHYL-9-OXOPROSTA-2,13-DIEN-1-OICACID;11α,15S-Dihydroxy-17S,20-dimethyl-9-oxo-prosta-2E,13E-dien-1-oic acid;(2E)-7-[(1R,2R,3R)-3-Hydroxy-2-[(1E,3S,5S)-3-hydroxy-5-methyl-1-nonen-1-yl]-5-oxocyclopentyl]-2-heptenoic acid;ONO1206;OP1206;D02722;LIMAPROST [WHO-DD];17alpha,20-dimethyl-delta2-PGE1;Limaprost alfadex [JAN];CHEMBL2107456;OP-1206.alpha-CD;Limaprost, >=99%, crystalline;2-Heptenoic acid, 7-((1R,2R,3R)-3-hydroxy-2-((1E,3S,5S)-3-hydroxy-5-methyl-1-nonenyl-5-oxocyclopentyl)-, (2E)-;NCGC00344134-02;(E)-7-((1R,2R,3R)-3-hydroxy-2-((3S,5S,E)-3-hydroxy-5-methylnon-1-en-1-yl)-5-oxocyclopentyl)hept-2-enoic acid;HY-B0683;17a,20-dimethyl-o2-PGE1;NS00069853;ONO-1206;SR-01000946415;Limaprost (INN);9-Oxo-11-alpha,15-alpha-dihydroxy-17S,20-dimethylprosta-trans-2,trans-13-dienoic acid;17-S-methyl-omega-homo-trans-delta(2)-prostaglandin E1;SR-01000946415-1;Limaprost [INN];Limaprost alpha-cyclodextrin;LIMAPROST ALFADEX [WHO-DD];limaprost-alfadex;CHEBI:135594;(E)-7-((1R,3R)-3-hydroxy-2-((3S,5S,E)-3-hydroxy-5-methylnon-1-en-1-yl)-5-oxocyclopentyl)hept-2-enoic acid;L02U804092;MFCD00868275;Limaprostum [Latin];DB09211;OP120617a,20-dimethyl-o2-PGE1;LIMAPROST [MI];AKOS016010151;Limaprost alpha-cyclodextrin clathrate;MS-26232;SCHEMBL373011;Q22075873;OP-1206;UNII-L02U804092;LIMAPROST .ALPHA.-CYCLODEXTRIN CLATHRATE;LIMAPROST [MART.];(2E,11-alpha,13E,15S,17S)-11,15-Dihydroxy-17,20-dimethyl-9-oxoprosta-2,13-dien-1-oic acid;Limaprostum;HMS3648D21;Prosta-2,13-dien-1-oic acid, 11,15-dihydroxy-17,20-dimethyl-9-oxo-, (2E,11alpha,13E,15S,17S)-;EX-A4260;J-501991;Ono-1206.alpha-CD;F85020;DTXSID701018146;LIMAPROST [JAN];74397-12-9;Limaprostst;(2E)-7-{(1r,2r,3r)-3-hydroxy-2-[(1e,3s,5s)-3-hydroxy-5-methylnon-1-en-1-yl]-5-oxocyclopentyl}hept-2-enoic acid (non-preferred name);DTXCID401476393;(2E)-7-{(1R,2R,3R)-3-Hydroxy-2-[(1E,3S,5S)-3-hydroxy-5-methylnon-1-en-1-yl]-5-oxocyclopentyl}hept-2-enoic acid;11.alpha.,15S-Dihydroxy-17S,20-dimethyl-9-oxoprosta-2E,13E-dien-1-oic acid;(2E)-7-[(1R,2R,3R)-3-hydroxy-2-[(1E,3S,5S)-3-hydroxy-5-methylnon-1-en-1-yl]-5-oxocyclopentyl]hept-2-enoic acid;11alpha,15S-Dihydroxy-17S,20-dimethyl-9-oxoprosta-2E,13E-dien-1-oic acid;Limaprostum (Latin);SBI-0654086.0001;85679-52-3;(2E)-7-((1R,2R,3R)-3-Hydroxy-2-((1E,3S,5S)-3-hydroxy-5-methylnon-1-en-1-yl)-5-oxocyclopentyl)hept-2-enoic acid;(E)-7... |